Recent Advances in the Biochemistry and Biotechnology of Antibacterial Treatments

Dear Colleagues,

Due to the increased emergence of multidrug-resistant bacteria (“superbugs”), which put enormous pressure on health systems worldwide, antibacterial treatments are in more demand than ever. Equally relevant is fundamental research dedicated to elucidating by which mechanisms bacteria acquire multidrug resistance. Although antibiotics can kill many types of bacteria or at least inhibit their growth through “classic” targets, such as cell wall biosynthesis, the DNA replication and protein production of bacteria are slowly but surely being exhausted. New leads and strategies desperately need to be prepared for treating bacterial infections effectively in the years to come.

This Special Issue on “Recent advances in the biochemistry and biotechnology of antibacterial treatments” seeks high-quality works focusing on the latest advances in the development of strategies to combat bacteria. Topics include, but are not limited to, the following:

• Natural-product-based antibiotic discovery.
• CRISPR-Cas9-based treatments.
• Phage therapy.
• Elucidation of general bacterial resistance mechanisms.
• Research dedicated to unraveling the expression of multidrug resistance phenotypes in particular.
• Immunoglobulin therapy.
• Antisense RNA-based treatments.
• Nanotechnology approaches to combat bacterial infections.

Prof. Dr. Christian Quintus Scheckhuber
Prof. Dr. Angel David Reyes-Figueroa
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Processes is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.